Key result
COMPASS-31 and Ewing's test show the best agreement for diagnosing diabetic autonomic neuropathy.
Why the study?
Methods to diagnose diabetic autonomic neuropathy often provide inconsistent results, including conflicting findings between guideline-recommended Ewing's test and heart rate variability.
What is the degree of agreement between COMPASS-31, SSR, Ewing's test, and HRV in diagnosing diabetic autonomic neuropathy in patients with type 2 diabetes?
Cross-Sectional (n=126)
No
What is the degree of agreement between COMPASS-31, SSR, Ewing's test, and HRV in diagnosing diabetic autonomic neuropathy in patients with type 2 diabetes?
Effect estimate: κ = 0.512
p-value: p=<0.001
COMPASS-31 and Ewing's test demonstrate good diagnostic consistency and severity correlation for diabetic autonomic neuropathy, suggesting either is suitable for diagnosis and follow-up.
Highlights the clinical challenge of discordant diagnostic testing in diabetic autonomic neuropathy; leaves open.
Background: There are many methods to diagnose diabetic autonomic neuropathy (DAN); however, often, the various methods do not provide consistent results. Even the two methods recommended by the American Diabetes Association (ADA) guidelines, Ewing's test and heart rate variability (HRV), sometimes give conflicting results. The purpose of this study was to evaluate the degree of agreement of the results of the Composite Autonomic Symptom Score 31 (COMPASS-31), skin sympathetic reaction (SSR) test, Ewing's test, and HRV in diagnosing DAN. Methods: Patients with type 2 diabetes were recruited and each received the COMPASS-31, SSR, Ewing's test, and HRV for the diagnosis of DAN. Patients were categorized as DAN(+) and DAN(–) by each of the tests. Kappa consistency tests were used to evaluate the agreement of diagnosing DAN between any two methods. Spearman's correlation test was used to evaluate the correlations of the severity of DAN between any two methods. Receiver operating characteristic (ROC) analyses were used to evaluate the diagnostic value and the cutoff value of each method. Results: A total of 126 type 2 diabetic patients were included in the study. The percentages of DAN(+) results by HRV, Ewing's test, COMPASS-31, and SSR were 61, 40, 35, and 33%, respectively. COMPASS-31 and Ewing's test had the best agreement for diagnosing DAN (κ = 0.512, p < 0.001). COMPASS-31 and Ewing's test also had the best correlation with respect to the severity of DAN (r = 0.587, p < 0.001). Ewing's test and COMPASS-31 had relatively good diagnostic values (AUC = 0.703 and 0.630, respectively) in the ROC analyses. Conclusions: COMPASS-31 and Ewing's test exhibit good diagnostic consistency and severity correlation for the diagnosis of DAN. Either test is suitable for the diagnosis of DAN and treatment follow-up.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2021) conducted a cross-sectional in Diabetic Autonomic Neuropathy (n=126). Four diagnostic methods (COMPASS-31, SSR, Ewing's test, HRV) vs. Each other (diagnostic agreement) was evaluated on Agreement of diagnosing diabetic autonomic neuropathy between COMPASS-31 and Ewing's test (κ = 0.512, p=<0.001). COMPASS-31 and Ewing's test exhibited the best agreement (κ = 0.512) and severity correlation (r = 0.587) for diagnosing diabetic autonomic neuropathy among the four methods evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: